Health in Cuba

999 indicators covering health for Cuba.

IndicatorLatest Year10-yr change Rank
Reported number of people requiring interventions against NTDs 1,137 2024 down 97.7% 116th
Child deaths from streptococcus by disease 8 2015 down 33.3% 94th
Births attended by skilled health personnel 99.8% 2024 up 0.8% 33rd
Percentage of total deaths due to NCDs overall and percentage of total 34.61 2021 up 339.9% 56th
Number of new leprosy cases 151 2024 down 28.1% 44th
Pharmacists 5.37 2022 up 108.1% 69th
Low birth weight prevalence 7.1% 2020 down 1.4% 119th
Inactivated first-dose polio vaccine (IPV1) immunization coverage amon 99.0% 2025 β€” 1st
Low birth weight number 7.5 2020 down 19.4% 97th
Number of new hivaids infections who 1,800 2024 down 14.3% 58th
Reported rabies deaths 1 2024 β€” 46th
Number of current cigarette smokers, estimate 779,000 2030 down 36.5% 83rd
Reported number of children receiving antiretroviral therapy 34 2025 up 21.4% 91st
Concentrations of fine particulate matter 13.09 2023 down 24.2% 123rd
Death rate road traffic injuries 8.9 2019 up 7.2% 129th
New or unknown treatment history cases: Pulmonary, bacteriologically c 520 2023 up 7.4% 119th
Medical doctors not further defined 94,066 2022 up 14.6% 13th
Life satisfaction vs life expectancy 78.08 2023 up 0.1% 74th
Estimate of current cigarette smoking prevalence 8.7% 2030 down 34.6% 106th
Estimate of current cigarette smoking prevalence (%) 8.1% 2030 down 35.7% 111th
Tb patients tested positive for hiv 27 2021 down 56.5% 106th
Number of children aged 6-59 months with anaemia 106.61 2019 down 25.1% 111th
Prevalence of anaemia in children aged 6-59 months 18.1% 2019 down 22.3% 149th
Number of deaths attributed to non-communicable diseases, by type of d 26,175 2019 up 21.4% 49th
Hepatitis B surface antigen (HBsAg) prevalence 0.0% 2024 β€” 132nd
Mean hemoglobin level of children aged 6-59 months 120 2019 up 1.7% 36th
Estimated number of MDR/RR-TB incident cases 60 2024 up 160.9% 107th
Mortality caused by road traffic injury 8.9 per 100,000 population 2019 up 1.1% 130th
Mortality caused by road traffic injury, female 3.5 per 100,000 female population 2019 up 2.9% 138th
Mortality caused by road traffic injury, male 14.4 per 100,000 male population 2019 up 0.7% 128th
Ipv vaccine coverage 99 2024 unchanged 1st
Tb patients living with hiv receiving art 27 2021 down 50.9% 96th
HIV-positive TB patients on ART (antiretroviral therapy) 100.0% 2024 up 20.5% 1st
Hospital beds 43.29 2023 up 7.0% 32nd
Treatment success rate for patients treated for MDR-TB 67.0% 2022 unchanged 106th
New leprosy case detection rate per 1 000 000 population 13.75 2024 down 26.3% 38th
Treatment success rate: HIV-positive TB cases 79 2023 up 38.6% 58th
Bladder cancer death rate 3.08 2021 up 1.2% 23rd
Cancer death rates by type who db 3.08 2021 up 1.2% 23rd
Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) i 99.0% 2025 β€” 1st
International Health Regulations core capacity scores, SPAR version, 2 80 2025 β€” 25th
Leprosy registered prevalence rate per 1 000 000 population 16.21 2024 down 21.3% 39th
Leprosy - Number of new leprosy cases among children 1 2024 down 87.5% 59th
Leprosy - Number of cases registered for treatment 178 2024 down 23.3% 42nd
New leprosy child case detection rate (less than 15 years of age) per 0.596 2024 down 86.1% 53rd
Children (0-14) living with HIV 200 2024 unchanged 77th
Ipv1 number unvaccinated 957.44 2023 down 21.2% 144th
Children living with hiv 200 2024 unchanged 77th
Contraceptive prevalence, any method 62.1% 2022 down 16.4% 43rd
Children (ages 0-14) newly infected with HIV 100 2024 unchanged 51st
Number of reported cases of poliomyelitis by wild poliovirus 0 2023 β€” 3rd
Liver cancer death rate 3.96 2021 down 17.0% 65th
Number of children newly infected with hiv 100 2024 unchanged 51st
Share of children under fifteen years old with hiv 16.71 2024 down 54.0% 79th
Number of female leprosy new cases 63 2024 down 35.1% 40th
National smoking ban: NUMBER OF PLACES SMOKE-FREE 4 2022 unchanged 114th
Contraceptive prevalence, any modern method 60.1% 2022 down 17.9% 26th
Number of prevalent tuberculosis cases 1,500 2014 down 6.2% 120th
Number of new G2D leprosy cases 23 2024 up 360.0% 37th
Leprosy - New leprosy cases with G2D rate per 1 000 000 population 2.1 2024 up 379.3% 28th